Martin Institute Auditorium
Despite the depth and breadth of Alzheimer’s disease research, effective methods for treatment remain elusive. The emphasis on medical intervention has led to a more recent focus on identifying biomarkers decades before the threshold for clinical diagnosis is met and on developing earlier detection methods. Digital technologies such as wearable sensors and smart home devices may offer a solution for monitoring and detecting modifiable Alzheimer’s disease-related risk factors and behavioral symptoms well before changes meet the threshold for clinical diagnosis. These technologies could potentially lead to a more comprehensive focus on “personalized brain health” and reduce the likelihood of disease.
Registration: alzmassnh.org/alztalks or 800-272-3900
Free to attend. Light refreshments will be served.